Records containing: Hypogonadism, Male
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-22Improving Patient-Important Outcomes With Testosterone Replacement in Hypogonadal Men With a Prior History of Cancer
-
CLINICAL_TRIALS study record update · 2026-04-14Androgen Replacement to Improve Patient-Important Outcomes in Men With Opioid-Induced Hypogonadism
-
CLINICAL_TRIALS study record update · 2026-03-31Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency
-
CLINICAL_TRIALS study record update · 2026-02-23Safety of Intramuscular Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
-
CLINICAL_TRIALS study record update · 2026-02-18Open-Label, Multiple-Dose, 52-Week Study + 24-Month Long-Term Safety Extension to Evaluate the Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Deficiency or Absence of Endogenous Testosterone Due to Primary or Secondary Hypogonadism
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-02Utilizing EndoPAT Device for Endothelial Dysfunction Assessment in Erectile Dysfunction and Hormonal Therapy
-
CLINICAL_TRIALS study record update · 2026-01-09A Multi-center, Open-label, Single-arm 24-hour Ambulatory Blood Pressure Monitoring (ABPM) Study of Testosterone Cypionate Injection in Hypogonadal Men
-
CLINICAL_TRIALS study record update · 2025-12-17A Prospective Study of Testosterone Supplementation in Hypogonadal Patients Receiving a Renal Transplant
-
CLINICAL_TRIALS study record update · 2025-08-11Detection of Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Exposed to Cisplatin-based Chemotherapy and Bone Marrow Transplant
-
CLINICAL_TRIALS study record update · 2025-06-13The Effects of Intranasal Testosterone (NatestoTM) for Treatment of Hypogonadism on Maintenance of Spermatogenesis
-
CLINICAL_TRIALS study record update · 2025-04-10Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes: (FERTILE): Prospective Observational Study Evaluating Safety and Efficacy
-
CLINICAL_TRIALS study record update · 2025-03-30Effect of JATENZO® Therapy on Testosterone and Hemoglobin Concentrations in Hypogonadal Men with Chronic Kidney Disease
-
CLINICAL_TRIALS study record update · 2025-03-14An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment With Marketed Testosterone Products
-
CLINICAL_TRIALS study record update · 2025-01-06Salivary Testosterone in Men: Diurnal Variation and Post-prandial Responses
-
CLINICAL_TRIALS study record update · 2024-11-15Calciotropic Effects After HCG Stimulation Test
-
CLINICAL_TRIALS study record update · 2024-10-18A Phase 4, Open-Label, Single-Arm Study to Evaluate the Effects of Vogelxo(R) on 24-hour Ambulatory Blood Pressure Monitoring in Hypogonadal Men Using Therapeutic Testosterone Replacement Therapy
-
CLINICAL_TRIALS study record update · 2024-08-09ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer (EROS)
-
CLINICAL_TRIALS study record update · 2024-06-28A 6 Month, Open Label, Ambulatory Blood Pressure Monitoring (ABPM) Extension Study
-
CLINICAL_TRIALS study record update · 2024-04-24The Effects of Natesto For Treatment Of Hypogonadism On Maintenance Of Spermatogensis.
-
CLINICAL_TRIALS study record update · 2024-03-15Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17 With Oral Curcumin in Normal Men With Experimental Hypogonadism
-
CLINICAL_TRIALS study record update · 2024-03-1352 Week RCT to Investigate the Effect of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Obese/Overweight Men With T2DM/Prediabetes and Hypogonadism and Subsequent 108 Week Open Label Phase to Investigate Effects on Cardiometabolic Parameters
-
CLINICAL_TRIALS study record update · 2024-03-12Physical Exercise as a Sustainability Tool in Men Affected With Metabolic Syndrome-related Late-onset Central Hypogonadism: Role of Endocrine-metabolic and Neurovegetative Outcomes
-
CLINICAL_TRIALS study record update · 2024-02-15A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids on Plasma Reproductive Hormones, Fertility, Withdrawal Symptoms and Myocardial Function - The LUCAS Trial
-
CLINICAL_TRIALS study record update · 2023-12-13A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections: A Phase IV, Prospective, Randomized, Non-Blinded, Multi-Institutional Study
-
CLINICAL_TRIALS study record update · 2023-06-28A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)